Cargando…
Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction
High hydrostatic pressure specifically devitalizes cells and tissues without major changes in their molecular structure. Hence, high hydrostatic pressure may enhance the development of whole-cell anti-tumor vaccines, representing tumor heterogeneity and thus (neo-) antigen diversity. Moreover, safe...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593744/ https://www.ncbi.nlm.nih.gov/pubmed/37872173 http://dx.doi.org/10.1038/s41420-023-01671-z |
_version_ | 1785124496500326400 |
---|---|
author | Maletzki, Claudia Freiin Grote, Vivica Kalle, Friederike Kleitke, Thoralf Zimpfer, Annette Becker, Anne-Sophie Bergmann-Ewert, Wendy Jonitz-Heincke, Anika Bader, Rainer Vollmar, Brigitte Hackenberg, Stephan Scherzad, Agmal Mlynski, Robert Strüder, Daniel |
author_facet | Maletzki, Claudia Freiin Grote, Vivica Kalle, Friederike Kleitke, Thoralf Zimpfer, Annette Becker, Anne-Sophie Bergmann-Ewert, Wendy Jonitz-Heincke, Anika Bader, Rainer Vollmar, Brigitte Hackenberg, Stephan Scherzad, Agmal Mlynski, Robert Strüder, Daniel |
author_sort | Maletzki, Claudia |
collection | PubMed |
description | High hydrostatic pressure specifically devitalizes cells and tissues without major changes in their molecular structure. Hence, high hydrostatic pressure may enhance the development of whole-cell anti-tumor vaccines, representing tumor heterogeneity and thus (neo-) antigen diversity. Moreover, safe devitalization of tumor-infiltrated supporting tissue may facilitate reimplantation for functional reconstruction. However, precise high hydrostatic pressure thresholds for safe cancer cell killing are unknown. Here, we show that high hydrostatic pressure of at least 450 MPa is necessary to safely devitalize head and neck squamous cell cancer. A pressure of 300 MPa, which has been used frequently in cancer vaccine preparation, resulted in partial devitalization with 27% live cells in flow cytometry and 4% remaining autofluorescence in cell culture after one week. The remaining cells could form vital tumors in the chorioallantoic membrane assay. In contrast, 450 MPa killed all cells in vitro and prevented tumor outgrowth in ovo. The effectiveness of 450 MPa was attributed to the induction of DNA double-strand breaks, independent of apoptosis, autophagy, or methuosis. Furthermore, 450 MPa continued to induce immunogenic cell death. Our results demonstrate that 450 MPa of high hydrostatic pressure induces safe and sustained devitalization of head and neck cancer cells and tissues. Because of the heterogeneity in pressure resistance, we propose our approach as a starting point for determining the precise thresholds for other cancer entities. Further studies on head and neck cancer should focus on immunological co-cultures, combinations of immune checkpoint inhibition, and accurate anatomical reconstruction with pressure-treated autografts. [Image: see text] |
format | Online Article Text |
id | pubmed-10593744 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-105937442023-10-25 Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction Maletzki, Claudia Freiin Grote, Vivica Kalle, Friederike Kleitke, Thoralf Zimpfer, Annette Becker, Anne-Sophie Bergmann-Ewert, Wendy Jonitz-Heincke, Anika Bader, Rainer Vollmar, Brigitte Hackenberg, Stephan Scherzad, Agmal Mlynski, Robert Strüder, Daniel Cell Death Discov Article High hydrostatic pressure specifically devitalizes cells and tissues without major changes in their molecular structure. Hence, high hydrostatic pressure may enhance the development of whole-cell anti-tumor vaccines, representing tumor heterogeneity and thus (neo-) antigen diversity. Moreover, safe devitalization of tumor-infiltrated supporting tissue may facilitate reimplantation for functional reconstruction. However, precise high hydrostatic pressure thresholds for safe cancer cell killing are unknown. Here, we show that high hydrostatic pressure of at least 450 MPa is necessary to safely devitalize head and neck squamous cell cancer. A pressure of 300 MPa, which has been used frequently in cancer vaccine preparation, resulted in partial devitalization with 27% live cells in flow cytometry and 4% remaining autofluorescence in cell culture after one week. The remaining cells could form vital tumors in the chorioallantoic membrane assay. In contrast, 450 MPa killed all cells in vitro and prevented tumor outgrowth in ovo. The effectiveness of 450 MPa was attributed to the induction of DNA double-strand breaks, independent of apoptosis, autophagy, or methuosis. Furthermore, 450 MPa continued to induce immunogenic cell death. Our results demonstrate that 450 MPa of high hydrostatic pressure induces safe and sustained devitalization of head and neck cancer cells and tissues. Because of the heterogeneity in pressure resistance, we propose our approach as a starting point for determining the precise thresholds for other cancer entities. Further studies on head and neck cancer should focus on immunological co-cultures, combinations of immune checkpoint inhibition, and accurate anatomical reconstruction with pressure-treated autografts. [Image: see text] Nature Publishing Group UK 2023-10-23 /pmc/articles/PMC10593744/ /pubmed/37872173 http://dx.doi.org/10.1038/s41420-023-01671-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Maletzki, Claudia Freiin Grote, Vivica Kalle, Friederike Kleitke, Thoralf Zimpfer, Annette Becker, Anne-Sophie Bergmann-Ewert, Wendy Jonitz-Heincke, Anika Bader, Rainer Vollmar, Brigitte Hackenberg, Stephan Scherzad, Agmal Mlynski, Robert Strüder, Daniel Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction |
title | Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction |
title_full | Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction |
title_fullStr | Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction |
title_full_unstemmed | Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction |
title_short | Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction |
title_sort | establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593744/ https://www.ncbi.nlm.nih.gov/pubmed/37872173 http://dx.doi.org/10.1038/s41420-023-01671-z |
work_keys_str_mv | AT maletzkiclaudia establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction AT freiingrotevivica establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction AT kallefriederike establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction AT kleitkethoralf establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction AT zimpferannette establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction AT beckerannesophie establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction AT bergmannewertwendy establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction AT jonitzheinckeanika establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction AT baderrainer establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction AT vollmarbrigitte establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction AT hackenbergstephan establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction AT scherzadagmal establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction AT mlynskirobert establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction AT struderdaniel establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction |